Addus HomeCare’s (ADUS) “Overweight” Rating Reaffirmed at Stephens

Addus HomeCare (NASDAQ:ADUSGet Free Report)‘s stock had its “overweight” rating reaffirmed by analysts at Stephens in a research report issued to clients and investors on Wednesday,Benzinga reports. They currently have a $142.00 price target on the stock. Stephens’ price objective points to a potential upside of 52.06% from the stock’s current price.

ADUS has been the topic of several other research reports. JMP Securities assumed coverage on shares of Addus HomeCare in a research report on Monday, December 16th. They issued an “outperform” rating and a $150.00 target price on the stock. Royal Bank of Canada reiterated an “outperform” rating and issued a $136.00 price objective on shares of Addus HomeCare in a report on Thursday, November 14th. Citizens Jmp upgraded Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. Macquarie restated an “outperform” rating and issued a $129.00 target price on shares of Addus HomeCare in a research report on Thursday, February 27th. Finally, Oppenheimer lifted their price target on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, one has given a hold rating, seven have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $132.78.

Read Our Latest Analysis on Addus HomeCare

Addus HomeCare Price Performance

ADUS stock traded down $1.33 during mid-day trading on Wednesday, reaching $93.39. 16,711 shares of the company’s stock were exchanged, compared to its average volume of 198,976. The company has a market cap of $1.70 billion, a price-to-earnings ratio of 21.37, a price-to-earnings-growth ratio of 1.41 and a beta of 0.97. Addus HomeCare has a 12-month low of $87.88 and a 12-month high of $136.72. The stock’s 50 day moving average is $117.30 and its 200 day moving average is $124.04.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last announced its earnings results on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $297.14 million for the quarter, compared to analysts’ expectations of $291.04 million. On average, research analysts forecast that Addus HomeCare will post 4.59 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, CEO R Dirk Allison sold 25,000 shares of the company’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total value of $3,119,000.00. Following the completion of the sale, the chief executive officer now owns 79,397 shares of the company’s stock, valued at approximately $9,905,569.72. This represents a 23.95 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Corporate insiders own 4.60% of the company’s stock.

Institutional Investors Weigh In On Addus HomeCare

A number of hedge funds have recently added to or reduced their stakes in the business. Armis Advisers LLC purchased a new position in shares of Addus HomeCare in the 4th quarter valued at $295,000. Integrated Advisors Network LLC boosted its stake in Addus HomeCare by 8.5% in the fourth quarter. Integrated Advisors Network LLC now owns 4,261 shares of the company’s stock valued at $534,000 after acquiring an additional 333 shares in the last quarter. Public Employees Retirement System of Ohio purchased a new position in Addus HomeCare during the 4th quarter worth approximately $4,985,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Addus HomeCare by 43.7% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 48,727 shares of the company’s stock worth $6,108,000 after acquiring an additional 14,812 shares during the last quarter. Finally, Squarepoint Ops LLC purchased a new stake in Addus HomeCare in the 4th quarter valued at $389,000. 95.35% of the stock is currently owned by institutional investors and hedge funds.

About Addus HomeCare

(Get Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Recommended Stories

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.